Sign In
Buy BSTG
$2.47
+0.0200 (+0.82%)
At Close: Feb 07, 2020
Critical Comparison: Biostage (BSTG) & Its Rivals
06:22am, Sunday, 14'th Nov 2021 Dakota Financial News
Biostage (OTCMKTS: BSTG) is one of 192 public companies in the Surgical & medical instruments industry, but how does it compare to its peers? We will compare Biostage to related businesses based on the strength of its valuation, analyst recommendations, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Biostage and []
Biostage Reports Q2 2021 Financial Results
04:05pm, Friday, 13'th Aug 2021
HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Ce
Biostage Reports Q1 2021 Financial Results
04:05pm, Monday, 24'th May 2021
HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cell
